MJFF Announces $2-Million Funding Commitment to Drive Development of Parkinson's Disease Biomarker Pipeline
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
Disease biomarkers are distinctive biological features or changes that are consistently different in people with PD than in people without PD. Identifying one or more disease biomarkers would allow researchers to diagnose earlier, track disease progression and identify appropriate subjects for clinical trials. Drug biomarkers are critical for objectively assessing whether a given drug is reaching brain areas of interest and/or achieving a desired effect.
0 Comments
View Comments
- Companies:
- Michael J. Fox Foundation
Related Content
Comments